Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

182 trials

NCT07213440
Recruiting
Identification of Early Markers for ALS
Not applicable · France · 1 site
Registry update: 7 Jul 2026
NCT06147843
Recruiting
French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis
Not applicable · Germany, France · 9 sites
Registry update: 6 Aug 2026
NCT06735014
Recruiting
Multicenter ALS Imaging Study
Not applicable · United States · 3 sites
Registry update: 31 Jul 2026
NCT06596746
Recruiting
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Not applicable · Italy · 1 site
Registry update: 2 Sept 2026
NCT07380204
Recruiting
Quantification of Hsp90 in the Human Brain
Phase 1 · Belgium · 1 site
Registry update: 2 Feb 2026
NCT06351592
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Phase 1/2 · Australia, Belgium, Canada, Germany, Japan, South Korea, Poland, Sweden, Taiwan · 22 sites
Registry update: 11 Sept 2026
NCT06578195
Recruiting
ASSESS ALL ALS Study
Not applicable · Puerto Rico, United States · 37 sites
Registry update: 5 Nov 2026
2023-507195-43-00
Recruiting
A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD) patients
Phase 1 · Hungary · 1 site
Registry update: 1 Aug 2025
NCT06396260
Recruiting
Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect
Not applicable · Denmark · 1 site
Registry update: 29 Jan 2025
NCT06219759
Recruiting
Reinnervation and Neuromuscular Transmission in ALS
Not applicable · Denmark · 1 site
Registry update: 7 Aug 2024
NCT05983211
Recruiting
Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2
Not applicable · Canada · 1 site
Registry update: 19 Sept 2024
2022-502743-35-00
Recruiting
Evaluation of the efficacy and safety of Rituximab in patients with Amyotrophic Lateral Sclerosis (ALS)
Phase 2 · Germany · 3 sites
Registry update: 16 Oct 2026
NCT06021938
Recruiting
Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual Reality
Not applicable · France · 1 site
Registry update: 25 Feb 2026
NCT06172621
Recruiting
Spinal Cord Associative Plasticity for ALS
Not applicable · United States · 1 site
Registry update: 20 Mar 2026
NCT06765564
Recruiting
Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
Not applicable · China · 1 site
Registry update: 9 Jan 2025
NCT06844370
Recruiting
Home Versus Hospital Based NIV Care in MND
Not applicable · United Kingdom · 1 site
Registry update: 25 Feb 2025
NCT06344260
Recruiting
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)
Phase 2 · Italy · 4 sites
Registry update: 3 Apr 2024
2024-518888-35-00
Recruiting
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis: A multicenter, randomized placebo controlled and biological endpoints clinical Trial
Phase 2 · Italy · 4 sites
Registry update: 17 Dec 2025
NCT06429735
Recruiting
Precise Robotically IMplanted Brain-Computer InterfacE
Not applicable · United States · 2 sites
Registry update: 9 Jan 2026
NCT06051123
Recruiting
Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
Not applicable · Canada · 3 sites
Registry update: 17 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.